Live Breaking News & Updates on Corbus Pharmaceuticals Daily
Stay updated with breaking news from Corbus pharmaceuticals daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com downgraded shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) from a hold rating to a sell rating in a research report sent to investors on Saturday. A number of other research firms also recently issued reports on CRBP. Jefferies Financial Group raised shares of Corbus Pharmaceuticals from a hold rating to a buy rating […] ....
StockNews.com lowered shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) from a hold rating to a sell rating in a research report released on Saturday morning. A number of other brokerages have also recently issued reports on CRBP. Royal Bank of Canada assumed coverage on Corbus Pharmaceuticals in a research report on Monday, May 13th. […] ....
StockNews.com downgraded shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) from a hold rating to a sell rating in a research report released on Saturday. Other research analysts have also recently issued reports about the company. Oppenheimer boosted their price target on Corbus Pharmaceuticals from $58.00 to $60.00 and gave the stock an outperform rating […] ....
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Get Free Report)’s share price hit a new 52-week high on Tuesday . The stock traded as high as $50.30 and last traded at $50.00, with a volume of 58166 shares trading hands. The stock had previously closed at $48.55. Analyst Upgrades and Downgrades Several equities analysts recently weighed […] ....
Oppenheimer Increases Corbus Pharmaceuticals (NASDAQ:CRBP) Price Target to $60.00 wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.